| SKU | 2602 |
|---|---|
| Generic For | Voglibose |
| Generic Name | Voglibose |
| Manufacturer | Sun Pharmaceuticals Ltd, INDIA |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.74 | US$ 22.20 | |||
|
|||||
| 60 Tablet/s | US$ 0.67 | US$ 39.9610%US$ 44.40 | |||
|
|||||
| 90 Tablet/s | US$ 0.63 | US$ 56.6115%US$ 66.60 | |||
|
|||||
Volibo 0.3 mg contains Voglibose, which belongs to the group of drugs known as antidiabetics. It effectively treats patients with type 2 diabetes mellitus along with diet and exercise to improve glycaemic control. It helps to slow down the breaking down of food in our intestines to simple glucose, thereby decreasing the rise in blood sugar levels after meals. Lowering blood sugar levels is important when it comes to managing diabetes. If you can control the levels, you will reduce the risk of getting any of the serious complications of diabetes, such as eye damage, kidney damage, loss of limbs, and nerve problems.
Voglibose reduces the risk of dying from cardiovascular disease if you have Type 2 diabetes and already have cardiovascular disease. Regularly taking medicine with proper diet and exercise will help you live a healthy life. You should keep taking the tablet as prescribed because it helps prevent future complications.
Volibo 0.3 mg should not be used in patients with hypersensitivity to Voglibose or any of the ingredients of the medicine. The administration of Voglibose tablets should be limited to patients with established diabetes. Certain other medical conditions, such as abnormal glucose tolerance and positive urinary sugar, represent diabetes-like symptoms such as senile abnormal glucose tolerance, abnormal thyroid function, etc.
Volibo should be administered cautiously in patients with a history of laparotomy or ileus, patients with chronic intestinal disease, patients with aggravating symptoms due to increased generation of intestinal gas, and patients with serious hepatic or renal disorders. It is important to continue dietary restrictions with a regular distribution of carbohydrate intake during the day.
Patients who are overweight should continue their energy-restricted diet. When patients with diabetes are exposed to unusual stress, such as trauma, fever, infection, or surgery, a temporary loss of control of blood sugar may occur. For such situations, insulin therapy may be required for some time.
Voglibose is well-tolerated and effective in controlling blood sugar levels. But in some cases, it may cause side effects such as dizziness, abdominal pain, nausea, vomiting, flatulence, abnormal liver function, and dizziness. These common side effects don’t need medical attention and will resolve as your body adjusts to the dosage. But if you are experiencing serious or rare side effects, immediately seek medical help.
The dosage of Voglibose must be individualized based on tolerance and effectiveness observed in patients. The maximum suggested dose of 0.6 mg, thrice daily, should not be exceeded. In diabetics, a dose of 0.3 mg three times daily before meals has been effective, and it has been removed with diet treatment or diet plus or another antidiabetic agent. A change in dose must be recommended only if a response is not seen with 0.3 mg. Follow your doctor’s advice when it comes to taking this medicine. Your dose may differ from the one prescribed to you by your doctor.
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Login
Sign-up
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Login
Sign-up